Xilong Xiao
- Molecular Biology top 10%
- Organic Chemistry top 5%
- Molecular Medicine top 1%
- Epidemiology top 10%
- Pharmacology top 5%
- Topics
- Synthesis and Biological Evaluation (25 papers)Bioactive Compounds and Antitumor Agents (15 papers)Cancer therapeutics and mechanisms (12 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xilong Xiao
68 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 114
- Molecular Biology 939
- Organic Chemistry 473
- Molecular Medicine 392
- Epidemiology 310
- Pharmacology 301
Countries citing papers authored by Xilong Xiao
This map shows the geographic impact of Xilong Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xilong Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xilong Xiao more than expected).
Fields of papers citing papers by Xilong Xiao
This network shows the impact of papers produced by Xilong Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xilong Xiao. The network helps show where Xilong Xiao may publish in the future.
Co-authorship network of co-authors of Xilong Xiao
This figure shows the co-authorship network connecting the top 25 collaborators of Xilong Xiao. A scholar is included among the top collaborators of Xilong Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xilong Xiao. Xilong Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 39 | |
| 2 | 9 | |
| 3 | 1 | |
| 4 | 29 | |
| 5 | 9 | |
| 6 | 15 | |
| 7 | 11 | |
| 8 | 96 | |
| 9 | 78 | |
| 10 | 3 | |
| 11 | 40 | |
| 12 | 28 | |
| 13 | Autophagic process induced by olaquindox in HepG2 cells | 1 |
| 14 | 28 | |
| 15 | 30 | |
| 16 | 10 | |
| 17 | 11 | |
| 18 | 9 | |
| 19 | 46 | |
| 20 | 28 |
About Xilong Xiao
Xilong Xiao is a scholar working on Toxicology, Molecular Medicine and Organic Chemistry, having authored 68 papers that have together received 2.4k indexed citations. Recurring topics across this work include Synthesis and Biological Evaluation (25 papers), Bioactive Compounds and Antitumor Agents (15 papers) and Cancer therapeutics and mechanisms (12 papers). The work is most often cited by research in Molecular Medicine (392 citations), Toxicology (228 citations) and Pharmacology (237 citations). Xilong Xiao has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Shusheng Tang, Chongshan Dai, Tony Velkov, Daowen Li, Xi Jin, Yan Zhou, Qian Chen, Jian Li, Ting Zhang and Yang Wang. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Molecules and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.